For Southeast Asian businesses looking to sell medical devices on Alibaba.com to the US market, understanding FDA compliance is no longer optional—it's the foundation of market access. The regulatory landscape changed significantly on February 2, 2026, when the FDA's new Quality Management System Regulation (QMSR) took effect [1].
The QMSR represents a major shift in how medical device quality systems are regulated. Instead of maintaining separate compliance frameworks for different markets, the new regulation incorporates ISO 13485:2016 by reference, effectively harmonizing US requirements with international standards. This means suppliers who already hold ISO 13485 certification are significantly better positioned for FDA compliance.
For businesses on Alibaba.com international marketplace, this harmonization is good news. It reduces the compliance burden for suppliers serving multiple markets and creates clearer expectations for buyers evaluating potential partners. However, it also means that suppliers without proper quality management systems will face increasing barriers to market entry.
The QMSR final rule incorporates ISO 13485:2016 by reference, replacing the existing Quality System Regulation (21 CFR Part 820). This harmonization aims to streamline compliance for manufacturers serving multiple global markets while maintaining FDA's oversight authority [1].

